Alexander K. Arrow - Net Worth and Insider Trading

Alexander K. Arrow Net Worth

The estimated net worth of Alexander K. Arrow is at least $71,871 dollars as of 2024-04-26. Alexander K. Arrow is the CFO of Protagenic Therapeutics Inc and owns about 45,815 shares of Protagenic Therapeutics Inc (PTIX) stock worth over $71,870. Alexander K. Arrow is also the President and COO of Biolase Inc and owns about 9 shares of Biolase Inc (BIOL) stock worth over $1. Details can be seen in Alexander K. Arrow's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Alexander K. Arrow has not made any transactions after 2023-10-12 and currently still holds the listed stock(s).

Transaction Summary of Alexander K. Arrow

To

Alexander K. Arrow Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Alexander K. Arrow owns 4 companies in total, including Protagenic Therapeutics Inc (PTIX) , Biolase Inc (BIOL) , and 8i Acquisition 2 Corp (LAX) among others .

Click here to see the complete history of Alexander K. Arrow’s form 4 insider trades.

Insider Ownership Summary of Alexander K. Arrow

Ticker Comapny Transaction Date Type of Owner
PTIX Protagenic Therapeutics Inc 2023-10-12 Chief Financial Officer
BIOL Biolase Inc 2014-07-22 director
LAX 8i Acquisition 2 Corp 2021-11-22 director
EUDA EUDA Health Holdings Ltd 2021-11-22 director

Alexander K. Arrow Latest Holdings Summary

Alexander K. Arrow currently owns a total of 2 stocks. Among these stocks, Alexander K. Arrow owns 45,815 shares of Protagenic Therapeutics Inc (PTIX) as of October 12, 2023, with a value of $71,870 and a weighting of 100%. Alexander K. Arrow also owns 9 shares of Biolase Inc (BIOL) as of July 22, 2014, with a value of $1 and a weighting of 0%.

Latest Holdings of Alexander K. Arrow

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PTIX Protagenic Therapeutics Inc 2023-10-12 45,815 1.57 71,870
BIOL Biolase Inc 2014-07-22 9 0.15 1

Holding Weightings of Alexander K. Arrow


Alexander K. Arrow Form 4 Trading Tracker

According to the SEC Form 4 filings, Alexander K. Arrow has made a total of 2 transactions in Protagenic Therapeutics Inc (PTIX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Protagenic Therapeutics Inc is the acquisition of 8,000 shares on October 12, 2023, which cost Alexander K. Arrow around $6,480.

According to the SEC Form 4 filings, Alexander K. Arrow has made a total of 0 transactions in Biolase Inc (BIOL) over the past 5 years. The most-recent trade in Biolase Inc is the acquisition of 1 shares on July 22, 2014, which cost Alexander K. Arrow around $14,999.

Insider Trading History of Alexander K. Arrow

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Alexander K. Arrow Trading Performance

GuruFocus tracks the stock performance after each of Alexander K. Arrow's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Alexander K. Arrow is 5.69%. GuruFocus also compares Alexander K. Arrow's trading performance to market benchmark return within the same time period. The performance of stocks bought by Alexander K. Arrow within 3 months outperforms 6 times out of 12 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Alexander K. Arrow's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Alexander K. Arrow

Average Return

11.63%

Average return per transaction

Outperforming Transactions

36%

4 out of 11 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 10.7 5.69 27.88 11.63 -6.53 -11.44
Relative Return to S&P 500(%) 10.26 3.71 22.39 1.49 -19.73 -26.05

Alexander K. Arrow Ownership Network

Ownership Network List of Alexander K. Arrow

No Data

Ownership Network Relation of Alexander K. Arrow


Alexander K. Arrow Owned Company Details

What does Protagenic Therapeutics Inc do?

Who are the key executives at Protagenic Therapeutics Inc?

Alexander K. Arrow is the Chief Financial Officer of Protagenic Therapeutics Inc. Other key executives at Protagenic Therapeutics Inc include director & 10 percent owner & See Remarks Garo H Armen , COO / Interim President Robert Ziroyan , and director & Chief Executive Officer Edward J Gildea .

Protagenic Therapeutics Inc (PTIX) Insider Trades Summary

Over the past 18 months, Alexander K. Arrow made 1 insider transaction in Protagenic Therapeutics Inc (PTIX) with a net purchase of 8,000.

In summary, during the past 3 months, insiders sold 0 shares of Protagenic Therapeutics Inc (PTIX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Protagenic Therapeutics Inc (PTIX) were sold and 8,000 shares were bought by its insiders, resulting in a net purchase of 8,000 shares.

Protagenic Therapeutics Inc (PTIX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Protagenic Therapeutics Inc Insider Transactions

No Available Data

Alexander K. Arrow Mailing Address

Above is the net worth, insider trading, and ownership report for Alexander K. Arrow. You might contact Alexander K. Arrow via mailing address: Po Box 3094, Redwood City Ca 94064.

Discussions on Alexander K. Arrow

No discussions yet.